NCT04395365

Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 442 (actual)
• Sponsor: University College, London · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A multicentre, interventional, double-blind, placebo-controlled, parallel-arm, phase 3, randomised controlled trial to evaluate the use of co-trimoxazole as primary prophylaxis for spontaneous bacterial peritonitis to improve overall survival

Detailed description

See above

Conditions

• Spontaneous Bacterial Peritonitis

Interventions

Type	Name	Description
DRUG	Co-Trimoxazole 960Mg Dispersible Tablet	Antibiotic prophylaxis of Spontaneous Bacterial Peritonitis
DRUG	Placebo oral tablet	Placebo

Timeline

• Start date: 2019-06-30
• Primary completion: 2025-10-01
• Completion: 2025-10-01
• First posted: 2020-05-20
• Last updated: 2023-11-18

Locations

1 site across 1 country: United Kingdom